Healthcare Services

Pemphigus Vulgaris Industry Poised for Rapid Growth, Forecast to Touch $2.79 Billion by 2030 at 7.5% CAGR

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pemphigus vulgaris market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Pemphigus Vulgaris Market reach by 2030 starting from 2026 levels?

The pemphigus vulgaris market has experienced robust expansion in recent years. Its value is projected to increase from $1.94 billion in 2025 to $2.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. Historically, this expansion has been driven by factors such as restricted awareness and late diagnosis, dependence on corticosteroids, inadequate access to dermatology specialists, the high expense of immunosuppressive treatments, and inconsistent clinical data and registries.

The pemphigus vulgaris market size is anticipated to experience robust expansion over the forthcoming years. This market is projected to reach $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. The expansion during this period stems from several factors, including the increasing uptake of targeted immunotherapies, broader application of biologics and monoclonal antibodies, wider availability of teledermatology and remote monitoring solutions, improvements in early detection diagnostic instruments, and heightened patient awareness alongside support initiatives. Key developments expected within the forecast timeframe encompass the escalating utilization of AI for prompt diagnosis and prognosis forecasting, the rising acceptance of genomics-driven personalized treatments, the incorporation of cloud and big data for managing patient information, the deployment of IoT-enabled devices for distant patient observation, and the adoption of smart manufacturing processes in the creation of immunosuppressive medications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22094&type=smp

Which Drivers Are Influencing Long-Term Growth In The Pemphigus Vulgaris Market?

The increasing occurrence of autoimmune diseases is projected to drive the expansion of the pemphigus vulgaris market in the future. These conditions involve the immune system erroneously targeting and harming the body’s own healthy cells, tissues, or organs. The rise in autoimmune disease prevalence can be attributed to factors such as genetic susceptibility, environmental catalysts, and shifts in lifestyle. Genetic elements are crucial, as individuals possessing a familial background of autoimmune diseases face a higher probability of developing them, owing to hereditary weaknesses in their immune systems. As autoimmune diseases proliferate because of genetic predisposition, environmental factors, and lifestyle modifications, there’s a corresponding increase in diagnoses for conditions such as pemphigus vulgaris, thereby boosting the need for innovative treatments. For example, the Mayo Clinic Health System, a US-based network of community medical facilities offering extensive healthcare services, reported in January 2025 that the worldwide incidence and prevalence of autoimmune diseases are climbing, with yearly increases calculated at 19.1% and 12.5%, respectively. Consequently, the widespread occurrence of autoimmune diseases is fueling the expansion of the pemphigus vulgaris market.

How Is The Pemphigus Vulgaris Market Divided Into Segments?

The pemphigus vulgaris market covered in this report is segmented –

1) By Diagnosis And Treatment: Diagnosis, Treatment

2) By Population Type: Pediatric, Adults, Geriatric

3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)

2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy

What Trends Are Expected To Impact The Competitive Landscape Of The Pemphigus Vulgaris Market?

Leading companies in the pemphigus vulgaris market are prioritizing investment solutions aimed at enhancing treatment effectiveness and broadening therapeutic possibilities. These investment solutions comprise financial plans and resources allocated towards treatment development, research, and market entry. For example, in January 2023, the Patient Access Network Foundation (PAN) Foundation, a US-based non-profit entity, introduced a financial assistance program offering up to $6,600 per year for eligible pemphigus vulgaris patients to cover deductibles, copays, and coinsurance costs. To qualify for this financial assistance, patients must be undergoing treatment for pemphigus vulgaris, possess Medicare health insurance that covers their required medications, and have an income at or below 400% of the federal poverty level. The PAN Foundation additionally provides transportation assistance and facilitates connections between patients and support organizations.

Which Key Players Are Driving Competition In The Pemphigus Vulgaris Market?

Major companies operating in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pemphigus-vulgaris-global-market-report

Which Region Is Projected To Lead The Pemphigus Vulgaris Market During The Forecast Period?

North America was the largest region in the pemphigus vulgaris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pemphigus vulgaris market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pemphigus Vulgaris Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22094&type=smp

Browse Through More Reports Similar to the Global Pemphigus Vulgaris Market 2026, By The Business Research Company

Pompe Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Pectinases Market Report 2026

https://www.thebusinessresearchcompany.com/report/pectinases-global-market-report

Recipe Pecan Market Report 2026

https://www.thebusinessresearchcompany.com/report/recipe-pecan-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795